PURPOSE: To identify risk factors for a decline in upper body function following treatment for early stage breast cancer. METHODS: We conducted a cross-sectional observational study of 213 women > 55 years of age newly diagnosed with early stage breast cancer interviewed three to five months following their definitive surgery. Patients were classified as having impaired upper body function related to their breast cancer treatment if: 1) they reported having no difficulty in performing any of three tasks requiring upper body function (pushing or pulling large objects; lifting objects weighing more than 10 pounds; and reaching or extending arms above shoulder level) prior to treatment, but reported that any of these tasks were somewhat or very difficult in the four weeks prior to interview, or 2) they reported that performing any of the three tasks requiring upper body function was somewhat difficult prior to treatment, but reported that any of these tasks were very difficult in the four weeks prior to interview. RESULTS: In multiple logistic regression models, both the extent and type of primary tumor therapy and cardiopulmonary comorbidity were significantly associated with a decline in upper body function following breast cancer treatment. CONCLUSION: Given the critical importance of upper body function in maintaining independent living, clinicians should consider the functional consequences of treatment when they discuss treatment options and post-operative care with older women who have early stage breast cancer.
PURPOSE: To identify risk factors for a decline in upper body function following treatment for early stage breast cancer. METHODS: We conducted a cross-sectional observational study of 213 women > 55 years of age newly diagnosed with early stage breast cancer interviewed three to five months following their definitive surgery. Patients were classified as having impaired upper body function related to their breast cancer treatment if: 1) they reported having no difficulty in performing any of three tasks requiring upper body function (pushing or pulling large objects; lifting objects weighing more than 10 pounds; and reaching or extending arms above shoulder level) prior to treatment, but reported that any of these tasks were somewhat or very difficult in the four weeks prior to interview, or 2) they reported that performing any of the three tasks requiring upper body function was somewhat difficult prior to treatment, but reported that any of these tasks were very difficult in the four weeks prior to interview. RESULTS: In multiple logistic regression models, both the extent and type of primary tumor therapy and cardiopulmonary comorbidity were significantly associated with a decline in upper body function following breast cancer treatment. CONCLUSION: Given the critical importance of upper body function in maintaining independent living, clinicians should consider the functional consequences of treatment when they discuss treatment options and post-operative care with older women who have early stage breast cancer.
Authors: Cindy K Blair; Avi Madan-Swain; Julie L Locher; Renee A Desmond; Jennifer de Los Santos; Olivia Affuso; Tony Glover; Kerry Smith; Joseph Carley; Mindy Lipsitz; Ayushe Sharma; Helen Krontiras; Alan Cantor; Wendy Demark-Wahnefried Journal: Acta Oncol Date: 2013-02-26 Impact factor: 4.089
Authors: Sandi C Hayes; Diana Battistutta; Anthony W Parker; Cherrell Hirst; Beth Newman Journal: Support Care Cancer Date: 2004-11-18 Impact factor: 3.603
Authors: Marquita S Gray; Suzanne E Judd; Richard Sloane; Denise C Snyder; Paige E Miller; Wendy Demark-Wahnefried Journal: Cancer Causes Control Date: 2019-02-19 Impact factor: 2.506
Authors: Wendy Demark-Wahnefried; Elizabeth C Clipp; Miriam C Morey; Carl F Pieper; Richard Sloane; Denise Clutter Snyder; Harvey J Cohen Journal: J Clin Oncol Date: 2006-07-20 Impact factor: 44.544
Authors: Jeanne S Mandelblatt; Solomon B Makgoeng; Gheorghe Luta; Arti Hurria; Gretchen Kimmick; Claudine Isaacs; Michelle Tallarico; William T Barry; Brandy Pitcher; Eric P Winer; Clifford Hudis; Harvey J Cohen; Hyman B Muss Journal: J Geriatr Oncol Date: 2013-06-20 Impact factor: 3.599
Authors: Maria de Fátima Guerreiro Godoy; Maria Regina Pereira; Antonio Helio Oliani; Jose Maria Pereira de Godoy Journal: Int J Med Sci Date: 2012-05-28 Impact factor: 3.738